
hVIVO plc
OPORFOTCHealthcare● Active
$0.35
+$0.26(+306.50%)
Market Cap$240940378
P/E Ratio—
52W High$0.35
52W Low$0.0861
hVIVO plc(OPORF)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · OPORF · 截至 Jun 9, 2026
关键指标
探索 hVIVO plc 数据
oporf stock data · financials财务快照
完整财报FY 2025Revenue$46.8M▼ 25.44% YoY
202320242025
hvivo plc revenue · oporf revenue 2025FY 2025Net Income-$6.0M▼ 156.25% YoY
202320242025
hvivo plc net income · oporf profit 2025FY 2025EPS$-0.01▼ 155.41% YoY
202320242025
oporf eps · hvivo plc earnings per share 2025竞争对手与同行
oporf competitors#TickerCompanyPriceChangeMkt Cap
#1hVIVO plc
$0.35+306.50%$240.9M#2Benchmark Holdings plc
$0.37+0.00%$225.1M#3China Evergrande New Energy Vehicle Group Limited
$0.00+0.00%$2.2M#4Frontage Holdings Corporation
$0.15+36.36%$304.2M#5Genfit S.A.
$9.50+0.00%$475.8M#6Hansa Biopharma AB (publ)
$2.90+0.00%$245.8M股票表现
完整历史1D+306.50%
1W+306.50%
1M+306.50%
3M+306.50%
YTD+45.83%
1Y+45.83%
5Y-23.91%
关于 hVIVO plc
hVIVO plc functions as a contract research organization and pharmaceutical service provider, primarily dedicated to evaluating vaccines and antiviral medications. This is achieved through specialized …
what is hvivo plc · oporf stock overview · hvivo plc company profile · who is hvivo plc ceo · oporf OTC · hvivo plc headquarters · hvivo plc business segments
关于股票概览与关键数据
hVIVO plc(OPORF)是 Biotechnology 行业的 Healthcare 类公司,于 Jun 5, 2020 在 OTC 上市。截至最近交易日,OPORF 股价为 $0.35,市值约为 $240.9M。过去12个月累计回报 +45.83%,年初至今回报 +45.83%。
2025 财年 hVIVO plc 营收 $46.8M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,hVIVO plc(OPORF)股价为 $0.35,在 OTC 上市,52周区间为 $0.09 – $0.35。
OPORF 最新股价OPORF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议